PetMed Express (NASDAQ:PETS) Stock Price Passes Above Two Hundred Day Moving Average – Should You Sell?

PetMed Express, Inc. (NASDAQ:PETS) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.85 and traded as high as $3.30. PetMed Express shares last traded at $3.23, with a volume of 92,397 shares.

Analyst Ratings Changes

A number of analysts recently issued reports on the stock. Weiss Ratings restated a “sell (e+)” rating on shares of PetMed Express in a research report on Monday, December 29th. Wall Street Zen lowered PetMed Express from a “hold” rating to a “sell” rating in a research note on Saturday, October 18th. One analyst has rated the stock with a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Sell” and a consensus price target of $3.20.

PetMed Express Trading Down 1.5%

The company has a market capitalization of $69.03 million, a PE ratio of -1.22 and a beta of 0.65. The company’s 50 day moving average price is $2.90 and its 200-day moving average price is $2.85.

Hedge Funds Weigh In On PetMed Express

A number of large investors have recently modified their holdings of PETS. Goldman Sachs Group Inc. lifted its stake in shares of PetMed Express by 59.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 33,209 shares of the company’s stock valued at $139,000 after purchasing an additional 12,360 shares in the last quarter. R Squared Ltd acquired a new position in PetMed Express during the second quarter valued at approximately $34,000. Truffle Hound Capital LLC acquired a new position in PetMed Express during the second quarter valued at approximately $399,000. Occudo Quantitative Strategies LP purchased a new stake in PetMed Express during the second quarter worth approximately $51,000. Finally, Bridgeway Capital Management LLC increased its position in shares of PetMed Express by 96.2% in the second quarter. Bridgeway Capital Management LLC now owns 40,800 shares of the company’s stock worth $135,000 after acquiring an additional 20,000 shares in the last quarter. 73.33% of the stock is currently owned by hedge funds and other institutional investors.

PetMed Express Company Profile

PetMed Express, Inc operates as an online and catalog-based pet pharmacy and retail supplier under the 1-800-PetMeds brand name. The company distributes prescription and non‐prescription medications, nutritional supplements, flea and tick control products, and a range of pet health supplies directly to consumers. Through its licensed veterinary pharmacy in Delray Beach, Florida, PetMed Express fills orders for dogs, cats and other companion animals, offering both branded and generic products alongside its own private‐label formulations.

Founded in 1996 by Marc Puleo, PetMed Express built its business on the premise of convenience and cost savings for pet owners seeking reliable access to veterinary medications.